Clinical Trials Update: July 13, 2007
Emphysema HIV Memory Loss
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
This international study will evaluate the safety and effectiveness of a procedure called airway bypass to relieve hyperinflation (overfilling) of the lungs. The procedure is designed to improve lung function and reduce shortness of breath in people with severe homogeneous emphysema. Study participants must be 35 or older, and willing to stop smoking at least eight weeks before entering the trial. Candidates may not have had a stroke within past 12 months, or respiratory infections requiring more than three hospitalizations in the past year.
The research site is in Detroit, Mich.
This study will evaluate lozenges designed to treat oral warts in HIV-positive adults. Participants must have two or more warts in the mouth and be receiving a standard course of anti-retroviral therapy (HAART). Candidates may not be taking oral or injected steroids, or other drugs to treat oral warts.
The research site is in Philadelphia, Penn.
This 20-month research study will evaluate insulin therapy's effects on people with memory loss. To participate, you must be 55 or older.
The research site is in Los Angeles, Calif.
Copyright 2007 Thomson CenterWatch. All rights reserved.